New York State Common Retirement Fund
AVBP icon

New York State Common Retirement Fund’s ArriVent BioPharma AVBP Stock Holding History

New York State Common Retirement Fund’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Buy
14,783
+7,000
+90% +$207K ﹤0.01% 1990
2026
Q1 		$180K Hold
7,783
– – ﹤0.01% 2275
2025
Q4 		$157K Hold
7,783
– – ﹤0.01% 2393
2025
Q3 		$144K Hold
7,783
– – ﹤0.01% 2444
2025
Q2 		$169K Hold
7,783
– – ﹤0.01% 2328
2025
Q1 		$144K Hold
7,783
– – ﹤0.01% 2360
2024
Q4 		$207K Buy
7,783
+2,000
+35% +$57.4K ﹤0.01% 2276
2024
Q3 		$136K Buy
5,783
+2,900
+101% +$65.8K ﹤0.01% 2457
2024
Q2 		$53.5K Buy
+2,883
New +$51.4K ﹤0.01% 3069

Other funds holding AVBP

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund's AVBP Position: Q2 2026 in Review

New York State Common Retirement Fund increased its ArriVent BioPharma (AVBP) stake by 90% in Q2 2026, buying an estimated $207K and bringing the position to 14,783 shares worth $514K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

New York State Common Retirement Fund first reported a position in AVBP in Q2 2024 and has held it in 9 quarters since. 36 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • New York State Common Retirement Fund held 14,783 shares of ArriVent BioPharma worth $514K as of Q2 2026.
  • New York State Common Retirement Fund bought 7,000 ArriVent BioPharma shares in Q2 2026, an estimated $207K.
  • ArriVent BioPharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1990 holding.
  • New York State Common Retirement Fund first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 9 quarters since.
  • 36 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.